Related Experiment Video

Updated: Aug 11, 2026

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
14:32

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein

Published on: January 28, 2013

Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis

J A Fontana1, M I Dawson, M Leid

  • 1Department of Medicine, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA. Joseph.Fontana@med.va.gov

International Journal of Cancer
|May 8, 2000
PubMed

Insights

The retinoid AHPN (CD437) triggers cancer cell death by interacting with a novel protein, independent of known retinoid receptors (RARs/RXRs). This discovery offers new avenues for cancer therapy development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Retinoids are crucial in cell regulation, impacting proliferation and differentiation.
  • Many cancer cells resist conventional retinoid therapies.
  • The mechanism of action for some retinoids, like AHPN (CD437), remains unclear.

Purpose of the Study:

  • To investigate the molecular mechanism by which AHPN (CD437) induces apoptosis.
  • To identify the protein target of AHPN (CD437).
  • To determine if AHPN (CD437) acts through established retinoid signaling pathways.

Main Methods:

  • Competitive binding assays using nuclear extracts from HL-60R and MDA-MB-468 cells.
  • Size exclusion chromatography to characterize AHPN-binding proteins.

Main Results:

  • AHPN (CD437) binding was poorly competed by retinoic acid (tRA) or 9-cis-retinoic acid (9-cis-RA).
  • AHPN (CD437) did not compete with tRA or 9-cis-RA for binding to endogenous retinoid receptors.
  • Size exclusion chromatography identified a 95 kDa protein, distinct from RARs or RXRs, that binds AHPN (CD437).

Conclusions:

  • AHPN (CD437) induces apoptosis through a mechanism independent of the retinoic acid receptor (RAR) and retinoid X receptor (RXR) signaling pathways.
  • AHPN (CD437) likely interacts with a novel protein target.
  • This finding opens new therapeutic strategies targeting cancer cells resistant to traditional retinoids.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein08:18

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein

Published on: October 4, 2024

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...